Low documentation of chronic kidney disease among high-risk patients in a managed care population: a retrospective cohort study

Table 3 Predictors of Chronic Kidney Disease Documentation in multivariate analysis

CKD Diagnosis Documentation Prediction Variables	aOR of CKD documentation (95%CI)	P value
Age at baseline (by 1 year of increase)	0.98 (0.98-0.99)	< .0001
eGFR** 40-49 vs 50-59	2.55 (2.17-3.00)	< .0001
eGFR 40-39 vs 50-59	7.39 (6.19-8.82)	< .0001
eGFR 20-29 vs 50-59	18.37 (14.59-23.13)	< .0001
eGFR 10-19 vs 50-59	35.33 (25.14-49.65)	< .0001
Coronary artery disease	1.05 (0.87-1.25)	0.5882
Cerebrovascular disease	1.22 (0.80-1.85)	0.3477
Peripheral artery disease	1.51 (1.19-1.93)	0.0008
Chronic heart failure	1.44 (1.18-1.78)	0.0004
Statin use	1.22 (1.03-1.46)	0.0194
ACEI use	0.97 (0.82-1.15)	0.7673
NSAID use	0.81 (0.65-1.01)	0.0705

*Significant interactions in multivariate model were found between type 2 diabetes and gender with respect to CKD documentation (p value for interaction = 0.0053), as well as between type 2 diabetes and hypertension (p value for interaction = 0.0065) with respect to CKD documentation.
**eGFR in ml/min/1.73 m²

ISSN: 1471-2369